Body dysmorphic disorder in female Swedish dermatology patients

被引:12
|
作者
Brohede, Sabina [1 ,2 ,3 ]
Wyon, Yvonne [3 ,4 ]
Wingren, Gun [5 ]
Wijma, Barbro [6 ]
Wijma, Klaas [1 ]
机构
[1] Linkoping Univ, Unit Med Psychol, Dept Clin & Expt Med, Fac Med & Hlth Sci, Linkoping, Sweden
[2] Linkoping Univ, Dept Paediat, Linkoping, Sweden
[3] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
[4] Linkoping Univ, Dept Dermatol & Venereol, Linkoping, Sweden
[5] Linkoping Univ, Dept Clin & Expt Med, Fac Med & Hlth Sci, Occupat & Environm Med, Linkoping, Sweden
[6] Linkoping Univ, Fac Med & Hlth Sci, Dept Clin & Expt Med, Gender & Med, Linkoping, Sweden
关键词
NONPSYCHIATRIC MEDICAL-TREATMENT; COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; HOSPITAL ANXIETY; PREVALENCE; QUESTIONNAIRE; COMORBIDITY; VALIDATION; SYMPTOMS; ACNE;
D O I
10.1111/ijd.13739
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundIndividuals with body dysmorphic disorder (BDD) are highly distressed and impaired owing to perceived defects in their physical appearance that are not noticeable to others. They are frequently concerned about their skin and often present to dermatologists rather than psychiatrists. However, BDD patients attending dermatology clinics may be at risk of not receiving an appropriate assessment and beneficial treatment. The aims of this study were to estimate the BDD prevalence rate among Swedish female dermatology patients and to assess the psychological condition of BDD patients compared to that of other dermatology patients. MethodsThe occurrence of BDD was estimated using the Body Dysmorphic Disorder Questionnaire (BDDQ), a validated self-report measure for BDD. Symptoms of depression and anxiety were measured by the Hospital Anxiety and Depression Scale (HADS), and quality of life was assessed using the Dermatology Life Quality Index (DLQI). ResultsThe prevalence rate of BDD among female Swedish dermatology patients was 4.9% (95% CI 3.2-7.4). Anxiety (HADS A11) was 4-fold more commonly reported by patients with positive BDD screening (48% vs. 11%), and depression (HADS D11) was over 10-fold more common in patients with positive BDD screening (19% vs. 1.8%) (P<0.001). The median DLQI score was 18 in the BDD group, compared to a score of 4 in the non-BDD group (P<0.001). ConclusionsOur results indicate that BDD is fairly common among female Swedish dermatology patients (4.9%) and that BDD patients have high levels of depression and anxiety and severely impaired quality of life.
引用
收藏
页码:1387 / 1394
页数:8
相关论文
共 50 条